Life expectancy in Multiple sclerosis increases

Multiple sclerosis is an autoimmune disease that is not curable. Medications can slow the progression of the disease significantly. For the treatment of creeping forms have been approved for use in Germany new drugs, the very good results achieved, explains Prof. Dr. Christoph Kleinschnitz, Director of the clinic for neurology at the University hospital of Essen, for world MS day on may 30. May in an Interview with

What forms there are in the case of a Multiple sclerosis?

Small carving: In the case of Multiple sclerosis is typically between three forms are distinguished. The most common Form of the thrust is in the shape of remitting Multiple sclerosis (RRMS). This runs in batch mode. That is to say, it symptoms occur suddenly, for example, vision problems or spasticity, which subside after some time. After ten to 20 years, the relapsing Multiple sclerosis is not rare in the so-called secondary chronic-progressive over served progressive form (SPMS). The disease progresses slowly and continuously. Existing disabilities no longer are complete. Of these two delineate the primary chronic progressive form (PPMS). For this Form of MS onset of Disease to a slow progression of the disease without relapses is characteristic.

How läMS treat sst?

Kleinschnitz: Multiple sclerosis is an autoimmune disease. The available treatment options to draw in principle, the misdirected immune system back on track and intervene at various Points in the inflammatory processes. There is a wide range of immune therapies is available. Of tablets over injections and infusion therapies different dosage forms are available. All these medicines are pursuing in the broadest sense, the goal is to affect certain parts of the immune system.

The disease is still not curable. What progress has been made in medicine in the last few years?

Kleinschnitz: Curable in the classic sense is MS, not yet. In the meantime the available therapy options the life expectancy of Multiple sclerosis was increased in patients, however. It corresponds to today, the General life expectancy of healthy people. Affected often show fewer disabilities, can have a positive effect on the subjectively perceived quality of life.

Great progress has served as medicine in the treatment of primary chronic progressive and secondary chronic-progressive made history forms. As explained, these are the forms of MS where the disease progresses continuously, without relapses. For the treatment of new tablets, and an antibody therapy for 2018 and 2019 are available. Both the advance of the disease progression be slowed. The therapies regulate with the MS associated inflammatory processes and can cause the Affected less disabilities occur. The disease progress can be delayed also.


An Overview of all the messages you get on current.